CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
94 hedge funds and large institutions have $1.69B invested in China Biologic Products Holdings, Inc. in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
53% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 43
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
94
Holding in Top 10
2
Calls
$2.61M
Puts
$2.74M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$43.1M | |
| 3 | +$25.8M | |
| 4 |
CGI
Comgest Global Investors
Paris,
France
|
+$18.9M |
| 5 |
NSRI
New Silk Road Investment
Singapore
|
+$17.5M |
Top Sellers
| 1 | -$88M | |
| 2 | -$78.9M | |
| 3 | -$64.7M | |
| 4 |
ICP
Indus Capital Partners
New York
|
-$31.5M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$25.5M |